Validation of a simple method for the determination of glyphosate and aminomethylphosphonic acid in human urine by UPLC-MS/MS by Martín Reina, Jose et al.
Microchemical Journal 170 (2021) 106760
Available online 18 August 2021
0026-265X/© 2021 The Author(s). Published by Elsevier B.V. This is an open access article under the CC BY-NC-ND license
(http://creativecommons.org/licenses/by-nc-nd/4.0/).
Validation of a simple method for the determination of glyphosate and 
aminomethylphosphonic acid in human urine by UPLC-MS/MS 
Jose Martin-Reina a, Bouchra Dahiri a, Pilar Carbonero-Aguilar a, M. Eugenia Soria-Dıaz b, 
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A B S T R A C T   
Environmental pollutants such as pesticides can be detrimental to human health and/or to the environment. 
Their excessive use may produce toxicity through various mechanisms. Glyphosate is a broad-spectrum herbicide 
with a high worldwide distribution. Due to this, this chemical is classified as a ‘Group 2A – probably carcinogenic 
to humans’ by the International Agency for Research on Cancer. Human biomonitoring is considered the golden 
standard for exposure assessment and provides a very useful tool in public health. Therefore, it is important to 
develop methods to determine traces of this herbicide and its metabolite, aminomethyl phosphonic acid, in 
human biological samples. A new method for glyphosate and aminomethyl phosphonic acid determination in 
human urine is herein described and discussed. It is based on the derivatization procedure with Fluo-
renylmethoxycarbonyl chloride and quantification by ultra-performance liquid chromatography-tandem mass 
spectrometry. The method was optimized and suitably validated, with a linear range from 1 to 20 µg L− 1 in the 
case of glyphosate and 0.5–20 µg L− 1 for aminomethyl phosphonic acid. Limits of detection and quantification 
were 0.5 and 1 µg L− 1 for glyphosate and 0.1 and 0.5 µg L− 1 for aminomethyl phosphonic acid, respectively. 
Mean relative recoveries ranged 108–109% for glyphosate and 104–119% for aminomethyl phosphonic acid and 
intermediate precision values varied from 11.90 to 12.70% for glyphosate and 4.8–9% for aminomethyl phos-
phonic acid. The validated method has been applied in human urine from female farmers indirectly exposed to 
pesticides. This procedure can be used to monitor potential exposure of humans to glyphosate and aminomethyl 
phosphonic acid in epidemiological studies and for routine controls in public health.   
1. Introduction 
Human exposure to complex mixtures of environmental pollutants is 
a reality in society nowadays. Environmental pollutants refer to all of the 
exogenic, non-essential factors for humans, which, when released into 
the environment, can be detrimental to human health and/or to the 
environment [1]. Within this group of pollutants, some pesticides and 
metals stand out [2,3]. 
The use of pesticides in agriculture has allowed humans to obtain 
safer food by reducing vector-borne diseases. However, their excessive 
use may produce toxicity through various mechanisms [3]. General 
population is exposed to small concentrations of pesticides through diet 
and the environment throughout their lives, being more important this 
exposure on the population using them professionally [4]. 
Glyphosate (N-phosphonomethyl-glycine) (GLY) is a broad-spectrum 
herbicide with a high worldwide distribution, used in agricultural and 
forestry environments and also in non-agricultural areas such as water 
systems, parks, road verges, and gardens [5]. Concerning its toxici 
mechanism, it is thought that its true toxicity is caused by the surfactant 
that decouples elements of oxidative phosphorylation, which causes 
oxidative stress, although this is still controversial [6]. GLY has come 
under international debate since the International Agency for Research 
on Cancer (IARC) classified this chemical as a ‘Group 2A – probably 
carcinogenic to humans’ [7]. However, the United States Environmental 
Protection Agency has classified GLY in category IVpractically non-toxic 
and not an irritant [8]. In addition, in the European Union, GLY has been 
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thoroughly assessed by Member States, the European Food Safety Au-
thority (EFSA) and the European Chemicals Agency (ECHA), leading to 
its classification as non-carcinogenic to humans [9,10]. In 2017, the 
European Commission authorized the use of GLY for 5 years further 
[11]. 
Human biomonitoring (HBM), which involves the measurement of a 
chemical in biological substances such as blood, urine, hair, or milk is 
considered the golden standard for exposure assessment and provides a 
very useful tool in public health [12–14]. GLY is a non-persistent sub-
stance that tends to not be accumulated in the human body and conse-
quently is quickly metabolized and excreted via urine within 4–72 h 
after exposure [15]. The aminomethyl phosphonic acid (AMPA) is its 
major metabolite [16]. The HBM of GLY and its metabolite in urine is a 
useful strategy in order to obtain valuable information about recent 
internal exposure to pesticides (1–3 days) [15]. Also, HBM allows 
identification and elimination of possible sources of exposure, studying 
relationships between pollutants and health effects, identifying groups 
of populations vulnerable to these pollutants and setting priorities in 
environmental and health research [17]. 
Both GLY and AMPA are polar and amphoteric compounds that are 
very soluble in water which hinder their analysis [18,19]. Thus, it is 
necessary to employ tedious and time-consuming cleaning procedures in 
order to facilitate their chromatographic separation by GC, GC–MS, LC 
or LC–MS [20] or detection by Capillary Electrophoresis [21]. Several 
methods for GLY and AMPA analysis in different matrices, mainly in 
environmental samples, are reported in the literature [18,22–29]. Most 
of these methods are tedious for including numerous steps for the pu-
rification and derivatization of the compound. Derivatization proced-
ures can be made both pre-column and post-column. Pre-column 
procedures are based mainly on derivatization with 9-fluorenylmethyl 
chloroformate (FMOC) [22,23,26,30–33] to form fluorescent de-
rivatives (improve detection) and/or to reduce the polar character of the 
analytes facilitating the chromatographic retention [34]. The develop-
ment of new methods to reduce the steps in the analysis of these com-
pounds is of interest for the scientific community [35]. 
HBM studies of these compounds are scarce and have not been 
widely developed yet, reflecting the problems associated with this 
analysis. Thus, Jensen et al. [36] validated a procedure with an addi-
tional clean up step before the direct analysis of GLY and AMPA in 
human milk and urine by LC-MS/MS, without involving real samples. 
Later, McGuire et al. [16] applied this method in real human milk and 
urine samples, showing that the sensitivity of this method was not good 
enough to detect these compounds in human milk, while only traces 
were detected in urine samples. Parvaez et al. [37] also developed a 
procedure, detecting only GLY in human urine samples without deriv-
atization by LC-MS/MS. Furthermore, Connolly et al. [38] developed a 
new LC-MS/MS method to detect only GLY, not AMPA, in urine by 
including a previous solid phase extraction step which was applied to 
detect this compound in amenity horticulturalists first [38,39] and in 
the general young population later [40]. In view of these previous re-
sults, the aim of the present study was to develop a new validated 
method to detect both, GLY and AMPA, in human urine with a good 
sensitivity and without additional clean up steps. The optimization and 
validation of the proposed method was carried out according to the 
holistic approach [41,42]. The present procedure has been intended for 
routine determination in urine samples from farmers who handle GLY. 
2. Material and methods 
2.1. Chemicals and reagents 
Glyphosate (GLY), Aminomethylphosphonic acid (AMPA), and Flu-
orenylmethoxycarbonyl chloride (FMOC-Cl) were supplied by SIGMA-
–Aldrich Chemie GmbH (Steinheim, Germany). Standard solutions of 
GLY and AMPA were prepared in Milli-Q water (100 mg mL− 1) and 
diluted as required for their use as working solutions (0.5 – 20 ng mL− 1). 
All chemicals and reagents used in this study were analytical grade 
materials. Hydrochloric acid and acetonitrile were purchased from 
Merck (Darmstadt, Germany). Deionized water (418 MΩ/cm resistivity) 
was obtained from a Milli-Q water purification system (Millipore, Bed-
ford, USA). 
2.2. Derivatization procedure 
Several alternatives for derivatization of GLY and AMPA with FMOC- 
Cl were submitted to a preliminary evaluation, designing different 
procedures adapted to the aim of this work and based on the method 
from Demonte et al. [26], with different modifications that were 
adapted to our samples (human urine). Thus, different aspects were 
evaluated: volume and conditioning of the sample, concentration of the 
FMOC-Cl and buffer volume (Table 1). From the initial evaluation of the 
proposed approaches, the following method was finally selected for 
further optimization and validation: Blank urine samples (1 mL), pre-
viously homogenized, were spiked with different amounts of standards 
for calibration, between 0.5 and 20 µg L− 1 GLY and AMPA. Each quality 
control (QC) sample was prepared using blank urine samples (1 mL) 
spiked with the same standard stocks and working solutions of GLY and 
AMPA used in the calibration studies. The concentrations of the different 
QC samples were as follows: low QC level—0.5 µg L− 1 (GLY) and 
(AMPA); medium QC level—5 µg L− 1 of each compound; and high QC 
level—20 µg L− 1 of each compound. Once spiked, all the urine samples 
were submitted to lyophilization for 24 h. After that, the derivatization 
stage started with the addition of 5% borate buffer to achieve a pH 9, in 
which the derivatization reaction occurs, followed by the derivatization 
reagent, FMOC-Cl at an optimized concentration of 8 mg mL− 1. This 
reaction took place at a 60 ◦C for 30 min. Afterwards, 250 μL of HCl pH 1 
was added to stop the reaction and the samples were centrifuged (8 min, 
8000 rpm). Finally, samples were passed through a 0.2 μm filter before 
injection into the UPLC-MS/MS system. 
2.3. Chromatographic conditions 
Chromatographic separation was performed using an ultra high 
resolution liquid chromatograph (ACQUITY UPLC™, Waters, Milford, 
MA, USA) coupled to a Xevo TQ-S micro (Waters) consisting of a triple 
quadrupole mass spectrometer equipped with an electrospray ion source 
operated in positive mode. LC analyses were performed on an Acquity 
UPLC BEH® C18 column (particle size 1.7 μm, 2.1 × 100 mm). Injection 
volume was 10 µL and flow rate was 0.5 mL/min. Two different solvents 
were used as a mobile phase: Solvent A (Water 10 mM ammonium ac-
etate) and solvent B (Acetonitrile:Water 95:5 10 mM ammonium ace-
tate), the following gradient was used: 0.0–1.0 min 5% B, 1.0–7.0 min 
Table 1 
Detailed steps of the procedures under study.   
Option A Option B 
Sample volume 5 mL 1 mL 
Condition of the sample Without lyophilization Lyophilized 
Derivatization 1 mL borate buffer 5% 2 mL borate buffer 5% 
500 µL FMOC-Cl 1.5 g L− 1 2 mL FMOC-Cl 8 g L− 1  
Table 2 
Precursor and fragment m/z values for each specific compound and their 











20  392.0 Q 87.8 30   
q 179.1 10 
AMPA-FMOC 20  334.0 Q 155.8 20   
q 179.1 15  
a Q: transition used for quantification; q: transition used for confirmation. 
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Fig. 1. UPLC-MS/MS chromatogram for A) urine blank and B) urine blank spiked with GLY and AMPA standard (20 µg L− 1).  
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from 5% to 70% B, 7.0–9.0 min from 70% to 100% B, 9.0–10.0 min 
100% B, then 5% B up to 12.0 min. Multiple Reaction Monitoring 
(MRM) was applied where the precursor ions and fragments ions were 
monitored at Q1 and Q3, respectively. The m/z values for the precursor 
and fragment for each specific compound along with their respective 
cone voltages and collision energy values are shown in Table 2. For 
UPLC-ESI-MS/MS analyses, the mass spectrometer was set to the 
following optimized tune parameters: capillary voltage: 2.90 kV, source 
temperature: 150 ◦C, desolvation temperature: 350 ◦C, source des-
olvation gas flow: 650 L h− 1 and source cone gas flow: 50 L h− 1. Chro-
matographic and mass spectrometry data handling was performed using 
MassLynx software v 4.1 (Waters). 
2.4. Statistical criteria for method validation 
Once the method was developed, the next step was the validation to 
verify that it fulfills the requirements for its later application. Thus, the 
proposed method was validated taking into account the guidelines for 
the validation of analytical methods [43] regarding their linearity, 
sensitivity, precision and recovery parameters. 
A calibration curve was prepared for each compound; blank urine 
samples were spiked with standards of GLY and AMPA in different 
Fig. 1. (continued). 
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concentrations 0.5, 1, 2, 5, 10 and 20 μg L− 1 and injected in triplicate. To 
assess the matrix effect, we developed calibration curves in urine free of 
GLY and AMPA. 
Three validation standards covering the optimal working range were 
used, which were measured in triplicate for three different days. Three 
concentration levels (1, 5 and 20 μg L− 1) of GLY and (0.5, 5 and 20 μg 
L− 1) AMPA were spiked into urine samples in order to determine the 
repeatability and the precision through relative recovery assays. 
2.5. Application of the validated method in human urine samples 
2.5.1. Human subjects 
All procedures used in this study were approved by the Coordinating 
Committee of Ethics of the Biomedical Investigation of Andalucía 
(protocol number: 0231-N-17), and informed consent was obtained from 
each subject. A total of 20 women farmers were recruited from Mari-
naleda, Sevilla (Spain), which was part of a larger investigation about 
the possible toxic effects of the indirect pesticides exposition in women 
who collect fruits and vegetables in the field. This geographic location 
was targeted because it is an eminently agricultural municipality, whose 
economy is based on agricultural production. 
2.5.2. Urine collection and preservation 
Urine collection was carried out by the participants themselves, who 
were provided with a 125 mL polypropylene urine container and the 
urine collection instructions. A first-morning urine sample was collected 
from each volunteer. Samples were transported to the laboratory where 
they were subsampled and stored at − 80 ◦C prior to being lyophilized. 
As lyophilization increases the samples stability, once lyophilized, the 
samples were stored until their analysis. 
3. Results and discussion 
3.1. Pre-column derivatization with FMOC-Cl 
The concentration of sodium tetraborate is known to be critical, as an 
excess may interfere with the solvents of the chromatographic system, 
while a low concentration may lead to insufficient buffering capacity to 
complete the derivatization [26]. For this reason, two different volumes 
of the borate buffer (5%) were evaluated in the present study (Table 1). 
The final concentrations of the buffering reagent tested with reference to 
the starting volume of the sample were 2.3 g L− 1 for Option A and 6 g L− 1 
for option B. This concentration range is in agreement with others re-
ported in literature [26,44]. In this case, the option B was the one that 
allowed to achieve the results obtained. 
Both GLY and AMPA are very polar compounds that require a pre-
vious derivatization procedure to improve the sensibility and to detect 
trace levels by UPLC-MS/MS. FMOC-Cl is the most used compound to 
react at a room temperature with primary and secondary amines 
without needing a previous oxidation method. The required amount of 
this derivatizing reagent is also critical to ensure a complete and 
reproducible reaction, due to the presence of very high levels of amines 
on urine (in the forms of uric acid and urea). An excess of reagent must 
be used for the complete derivatization of the analytes present in the 
samples. This amount was experimentally determined in a range of 
concentrations between 1.5 and 8 g L− 1 of FMOC-Cl and in a range of 
volume added between 0.5 and 2 mL referred to the initial volume of 
sample considered in each tested procedure (Table 1). The optimization 
of this excess of FMOC-Cl is important since the unreacted reagent be-
comes an undesirable impurity and the formation of by-products occurs 
during the reaction [26]. In our case, 2 mL of FMOC-Cl 8 g L− 1 was used 
(method B). The selected method worked adequately, not introducing 
problems with the excess of reagent but reaching the optimum con-
centration to derivatize the GLY and AMPA present in urine samples and 
also the natural amines present in human urine. 
3.2. Matrix effects 
The matrix effects were determined in urine samples following the 
expression: ME = 100 × [(slope matrix/slope solvent) − 1], expressed in 
percentage. The values obtained were 23.02 for GLY and − 18.63 for 
AMPA, meaning mild matrix effect (|10| < ME < |20|) for AMPA and 
medium (|20| < ME < |50|) for GLY, so slight matrix effects were 
observed in the present work. Therefore, in order to obtain more accu-
rate results matrix-matched calibration curves were employed for 
quantification and validation procedure. 
3.3. Method validation 
In order to develop the UPLC–MS/MS for the detection of GLY and 
AMPA, commercially available standard solutions of these compounds 
were assayed to acquire mass spectra and adjust mobile phase strength. 
The first experiment carried out was to select the optimal ESI-MS pa-
rameters and the appropriate ions analyzing individual solutions of GLY 
and AMPA derivatized with FMOC-Cl to monitor the MS intensity. 
Although these compounds are usually analyzed in negative ion mode 
[25,31,36] it has been reported the positive ion mode analyzing as well 
[20,26,45]. In this case case, GLY and AMPA were analyzed in both 
negative and positive ion modes, obtaining greater sensitivity in the 
positive mode and, hence, this positive ion mode was selected. A major 
ion for each compound was evident in the mass spectra of the com-
pounds, m/z 392 for GLYP–FMOC and 334 for AMPA–FMOC, corre-
sponding to the protonated molecular ions [M + H]+. Multiple reactions 
monitoring (MRM) mode was used to obtain the maximum sensitivity 
for quantitative analysis (Table 2). In order to study the matrix effects on 
the ionization, both blank urine samples and blank urine samples spiked 
with GLY and AMPA solutions were prepared, and the peak areas of GLY 
and AMPA standard solutions (20 µg L− 1) prepared in blank urine 
samples were compared with the signal obtained in blank urine samples 
(Fig. 1A and B). 
The concentration-dependent responses were calculated from GLY 
Fig. 2. Huber plot for assessing the linear range of GLY (a) and AMPA (b) 
in urine. 
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and AMPA standards prepared in blank urine samples, and were 
measured by a 6-point calibration curve with a linear range within 
0.5–20 µg L− 1. The regression equations obtained were y = 4611x +
302.64 (R2 = 0.9998) and y = 1574.7x + 53.664 (R2 = 0.9992) for GLY 
and AMPA, respectively. 
3.3.1. Linearity 
Six different concentrations of GLY and AMPA were spiked to blank 
human urine (0.5–20 µg L− 1), submitting them to the proposed method. 
The calibration plot (signal response/analyte concentration against their 
concentrations) was established according to Huber [46] by replicate 
analysis (n = 3) at all concentration levels (Fig. 2). The target line had 
zero slopes and the intercept represents the median of the response 
factors obtained in a fashion similar to the action limits of control charts. 
Both parallel horizontal lines on the graphic represent the 0.95 and 1.05 
times the median value. As can be observed, no intersections with the 
lines were found in the case of AMPA, so the linear ranges of the methods 
apply to the full ranges studied. However, on the GLY representation, the 
0.5 value cannot be adjusted to the lineal ranges, discarding this con-
centration as lineal for our method. 
3.3.2. Sensitivity 
For validation purposes, it is normally sufficient to provide an indi-
cation of the level at which detection becomes problematic and quan-
tification is acceptable in terms of repeatability, precision and trueness. 
For this aim, the limits of detection (LOD) and quantitation (LOQ) were 
determined based on the standard deviation of the blank, by measuring 
10 independent urine sample blanks once each, and were estimated 
according to the equation YLOD or LOQ = Yblank + nSblank, where Yblank 
and Sblank are the average value of the blank signals and its corre-
sponding standard deviation. In these expressions, n = 3 in the case of 
LOD and n = 10 in the case of LOQ. Afterwards, YLOD and YLOQ values 
are converted into concentration units by using the calibration function. 
The LOD and LOQ obtained are 0.5 and 1 µg L− 1 for GLY and 0.1 and 0.5 
µg L− 1 for AMPA, respectively (Table 3). Other authors obtained values 
of 1 µg L− 1 for GLY LOD in urine using LC-MS [47], also 0.02 and 0.1 µg 
L− 1 for GLY and 0.03 and 0.1 µg L− 1 for AMPA for LOD and LOQ, 
respectively or 0.1 µg L− 1 for GLY LOD by LC-MS/MS [16,37]. Our 
values are similar to those obtained by Connoly et al. [48] in human 
urine (GLY LOQ: 0.5 µg L− 1) by LC-MS/MS. 
3.3.3. Precision 
Precision refers to the closeness of agreement between independent 
test results obtained under stipulated conditions, and according to the 
International Conference on Harmonisation Guidelines [43]. Thus, 
precision may be considered at three levels: repeatability, intermediate 
precision and reproducibility. The first one expresses the precision 
evaluated under the same experimental conditions over a short time 
interval, and it is termed as intra-assay or within-run. On the other hand, 
intermediate precision applies to within-laboratory variations: different 
days, different analysts or equipments, and it is sometimes called 
between-run or inter-assay precision [42]. The third level, reproduc-
ibility, expresses the precision between-laboratories in collaborative 
studies, and it will not be considered in this work. 
To assess the precision study, blank urine samples were spiked at 
three concentrations of GLY and AMPA standards (0.5, 2 and 20 µ L− 1), 
in triplicate (n = 3) within the same day, as recommended by the ICH 
guidelines, and over a period of three days. Afterward, they were sub-
jected to the proposed method and results were obtained. Considering 
three different days as the main source of variation, an analysis of 
variance (ANOVA) was performed for each concentration, obtaining 
estimates within-days (Sw), also known as repeatability, and between- 
day (SB). Also, the intra laboratory reproducibility or intermediate 
precision (SIP) was obtained [41,42]. All these parameters are shown in 
Table 3. From these data, the corresponding relative standard de-
viations, RSDIP are calculated, and were compared with the acceptable 
RSD percentages obtained from the AOAC Peer Verified Methods (PVM) 
program [42,46]. As a quick rule [42], the RSDIP results should be 
compared with one-half the corresponding RSD values tabulated. Our 
results, at the three concentration levels considered, were lower or the 
same order than the one-half %RSDAOAC tabulated, so the proposed 
method can be considered as precise (Table 3). 
3.3.4. Trueness and recovery 
The trueness of an analytical procedure expresses the closeness of 
agreement between the mean value obtained from a series of measure-
ments and the value which is accepted, either a conventional value or an 
accepted reference value like validation standard [42]. It can be ob-
tained from the same ANOVA results previously described for the in-
termediate precision, and it is normally expressed in terms of bias or 
recovery obtained for each validation standard considered [49]. These 
recoveries are defined as the ratio between the mean concentration of 
analyte measured in the fortified sample and the concentration of ana-
lyte added (“true” reference value, not determined by method) in the 
fortified sample, expressed as a percentage. The recoveries obtained for 
the three validation standards are shown in Table 3. 
They have been checked for suitability by comparison with the 
published acceptable recovery range as a function of the analyte con-
centration [42]. In our case, two concentrations of the three validation 
standards ranged between 0.5 and 5 µg L− 1, the recovery range (%) 
could oscillate between 40 and 120% for the two of them (GLY and 
AMPA). The third one validation standard was 20 µg L− 1 and the re-
covery range (%) could oscillate between 60 and 115% in both cases 
(GLY and AMPA). The recoveries obtained oscillated between these 
values 119% for 0.5 µg L− 1 (AMPA), 108 and 107% for 5 µg L− 1 (GLY 
and AMPA, respectively) and 109 and 104% for 20 µg L− 1 (GLY and 
AMPA, respectively). Thus, the method can be considered as acceptable 
in terms of recoveries. These recoveries are higher than those obtained 
by Bernal et al. [20] in rat serum samples by liquid chromatography–-
fluorescence–mass spectrometry method. This may be due to the nature 
of the samples, as urine has less interference than plasma. However, 
recently, Lopez-Ruiz et al. [50] have optimized a method to determine 
polar pesticides in human blood by LC-MS, obtaining recoveries of the 
same order as ours. Also, similar recoveries were obtained in human 
samples (milk and urine) by Jensen et al. [36] when a direct 
Table 3 
Estimations of within-condition repeatability (Sw), between-condition repeat-
ability (SB), intermediate precision (intra-laboratory reproducibility, SIP) and its 
relative standard deviations (%RSDIP), and recoveries of GLY and AMPA assayed 
in human urine, at three concentration levels, in three different days. Reference 
RSD values and recovery percentages by AOAC. Limits of detection (LOD) and 






5 µg L− 1 20 µg L− 1 
GLY AMPA GLY AMPA GLY AMPA 
SW 0.13 0.03 0.81 0.15 3.05 0.79 
SB 0.06 0.08 0.28 0.39 1.19 2.40 
SIP 0.11 0.05 0.68 0.26 2.59 1.53 
RSDIP(%) 10.8 9 12.70 4.8 11.90 7.3 
Relative 
Recovery 
(%) (n = 9) 
107 119 108 107 109 104 




40–120 40–120 40–120 40–120 60–115 60–115   
GLY AMPA 
LOD (µg L− 1) 0.5 0.1 
LOQ (µg L− 1) 1 0.5 
Linearity (µg 
L− 1) 
LOQ-20 LOQ-20  
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determination of GLY and AMPA by LC-MS/MS were applied. 
Taking into account these considerations, the analytical procedure 
developed in this work can be considered suitably validated. 
3.4. Comparison of the developed method with other methods 
There are several published methods to detect GLY and AMPA in 
different matrices (biological samples such as milk or environmental as 
soils and waters) and with several techniques (GC–MS, LC–MS, Capillary 
Electrophoresis…) [32–34,51]. However, these methods cannot be used 
for urine routine analysis without a previous validation in this biological 
matrix. On the other hand, there are some authors that employed 
different sample treatments to detect these contaminants in biological 
samples. Thus, Jensen et al. [36] developed a reliable method for 
determining GLY and AMPA in human urine including an additional 
clean up step. Recently, Franke et al. [52] developed a new method to 
detect GLY, AMPA and glufosinato from human urine by HRAM LC–MS, 
however, their method in urine was suited only for AMPA analysis. 
Similarly, Parvaez et al. [37] and Connolly et al. [38] developed both 
LC–MS/MS method but only detecting GLY in human urine samples 
without derivatization in the first case and including a previous solid 
phase extraction step in the second one. Thus, it can be concluded that 
the method from the present study is faster than the other options, as it 
does not require a pre-cleanup, while it is good enough to detect and 
quantify not only AMPA, but also GLY in cross-sectional studies. 
The effectiveness of the present method for the simultaneous 
extraction and determination of GLY and AMPA was compared with 
other recently published works. Table 4 summarizes the comparative 
results. 
3.5. GLY and AMPA determination in women farmers 
A total of 20 samples were analyzed using the proposed method. A 
blank sample and two quality controls were prepared and injected with 
the samples. Only one of the samples showed GLY positive results 
(Fig. 3) and all of them were negative in terms of AMPA detection 
(concentrations below LOQ). The GLY concentration detected was 2 µg 
L− 1. This result is similar to those detected previously in American 
farmers when urine was collected the same day of pesticides application 
(3.2 µg L− 1) [53]; after two days since application in French farmers (2 
µg L− 1) [47] or post-application in Irish farmers (1.72 µg L− 1) [38]. 
4. Conclusions 
In this study, a simple and fast UPLC–MS/MS method was developed 
and validated for the determination not only of GLY but also its 
metabolite AMPA in human urine, proving to be sensitive, reproducible, 
accurate and robust. The recoveries (108–109% GLY and 104–119% 
AMPA) and intermediate precisions obtained (11.90–12.70% GLY and 
4.8–9% AMPA) allow its validation. Moreover, it has been possible to 
apply the present method for detection and quantification of both 
compounds in human urine from women farmers, showing the presence 
of GLY in urine from one of the participants. For this reason, we can 
conclude that the novelty of the present method is to achieve the 
determination of both GLY and AMPA in human urine with rapid sample 
preparation and derivatization without an additional cleaning step as is 
usual in most published methods. This procedure can be used to monitor 
potential exposure of humans to GLY and AMPA in epidemiological 
studies and for routine controls in public health. 
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[24] T. Poiger, I.J. Buerge, A. Bächli, M.D. Müller, M.E. Balmer, Occurrence of the 
herbicide glyphosate and its metabolite AMPA in surface waters in Switzerland 
determined with on-line solid phase extraction LC-MS/MS, Environ. Sci. Pollut. 
Res. 24 (2017) 1588–1596. 
[25] D.P. Oulkar, S. Hingmire, A. Goon, M. Jadhav, B. Ugare, A.S. Thekkumpurath, et 
al., Optimization and validation of a residue analysis method for glyphosate, 
glufosinate, and their metabolites in plant matrixes by liquid chromatography with 
tandem mass spectrometry, J. AOAC Int. 100 (2017) 631–639. 
[26] L. Demonte, N. Michlig, M. Gaggiotti, C.G. Adam, H.R. Beldoménico, M.R. Repetti, 
Determination of glyphosate, AMPA and glufosinate in dairy farm water from 
Argentina using a simplified UHPLC-MS/MS method, Sci Total Environ. 645 (2018) 
34–43. 
[27] S. He, X. Cao, H. Wu, T. Li, M. Zhang, Y. Liang, B. Chen, Rapid determination of 
glyphosate, aminomethyl phosphonic acid, glufosinate, and ethephon residues in 
environmental water by direct injection-ultra performance liquid chromatography- 
triple quadrupole mass spectrometry, Chin. J. Chromatogr. 37 (11) (2019) 
1179–1184. 
[28] L. Carretta, A. Cardinali, E. Marotta, G. Zanin, R. Masin, A new rapid procedure for 
simultaneous determination of glyphosate and AMPA in water at sub μg/L level, 
J. Chromatogr. A 1600 (2019) 65–72. 
[29] J.P.F. Tiago, L.C. Sicupira, R.E. Barros, G.P. de Pinho, F.O. Silvério, Simultaneous 
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